Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tamoxifen as Adjuvant Treatment in Breast Cancer and Its Impact on Ovarian Function

NCT02355600 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria La Fe as lead sponsor.

NCT NCT02355600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02355600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tamoxifen as Adjuvant Treatment in Breast Cancer and Its Impact on Ovarian Function
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer